The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Journal: Evidence-based Cardiology. 2018;11(4): 28‑33

Read: 2076 times

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

. Evidence-based Cardiology. 2018;11(4):28‑33. (In Russ.)

МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Abstract:

Close metadata

References:

  1. Palmer B.F. Regulation of potassium homeostasis. Clin J Am Soc Nephrol 2015;10:1050—1060.
  2. Bielecka-Dabrowa A., Mikhailidis D.P., Jones L., et al. The meaning of hypokalemia in heart failure. Int J Cardiol 2012;158:12—17.
  3. Sarwar C.M., Papadimitriou L., Pitt B., et al. Hyperkalemia in heart failure. J Am Coll Cardiol 2016;68:1575—1589.
  4. Nilsson E., Gasparini A., Arnlov J., et al. Incidence and determinants of hyperkalemia and hypokalemia in a large healthcare system. Int J Cardiol 2017;245:277—284.
  5. Koh A.S., Tay W.T., Teng T.H.K., et al. A comprehensive population-based characterization of heart failure with mid-range ejection fraction. Eur J Heart Fail 2017;19:1624—1634.
  6. Nishihara T., Tokitsu T., Sueta D., et al. Serum potassium and cardiovascular events in heart failure with preserved left ventricular ejection fraction patients. Am J Hypertens 2018;31:1098—1105.
  7. Pitt B., Rossignol P. Relation of serum potassium to cardiovascular events in patients with heart failure and preserved ejection fraction: «mind the gap». Am J Hypertens 2018;31:1087—1089.
  8. Nallamothu B.K., Hayward R.A., Bates E.R. Beyond the randomized clinical trial: the role of effectiveness studies in evaluating cardiovascular therapies. Circulation 2008;118:1294—303.
  9. Thorvaldsen T., Benson L., Dahlstrom U., et al. Use of evidence-based therapy and survival in heart failure in Sweden 2003—2012. Eur J Heart Fail 2016;18:503—511.
  10. Trevisan M., de Deco P., Xu H., et al. Incidence, predictors and clinical management of hyperkalaemia in new users of mineralocorticoid receptor antagonists. Eur J Heart Fail 2018;20:217—1226.
  11. Aldahl M., Jensen A.C., Davidsen L., et al. Associations of serum potassium levels with mortality in chronic heart failure patients. Eur Heart J 2017;38: 2890—2896.
  12. Pitt B., Remme W., Zannad F., et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003;348:1309—1321.
  13. Zannad F., McMurray J.J., Krum H., et al. Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med 2011;364:11—21.
  14. Pitt B., Zannad F., Remme W.J., et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999;341:709—717.
  15. McMurray J.J., Packer M., Desai A.S., et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med 2014;371:993—1004.
  16. Pitt B., Pfeffer M.A., Assmann S.F., et al. Spironolactone for heart failure with preserved ejection fraction. N Engl J Med 2014;370:1383—1392.
  17. Desai A.S., Swedberg K., McMurray J.J, et al. Incidence and predictors of hyperkalemia in patients with heart failure: an analysis of the CHARM program. J Am Coll Cardiol 2007;50:1959—1966.
  18. Vardeny O., Claggett B., Anand I., et al. Incidence, predictors, and outcomes related to hypo- and hyperkalemia in patients with severe heart failure treated with a mineralocorticoid receptor antagonist. Circ Heart Fail 2014;7:573—579.
  19. Pitt B., Bakris G., Ruilope L.M., et al. Serum potassium and clinical outcomes in the Eplerenone Post- Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS). Circulation 2008;118:1643—1650.
  20. Rossignol P., Dobre D., McMurray J.J., et al. Incidence, determinants, and prognostic significance of hyperkalemia and worsening renal function in patients with heart failure receiving the mineralocorticoid receptor antagonist eplerenone or placebo in addition to optimal medical therapy: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF). Circ Heart Fail 2014;7:51—58.
  21. Desai A.S., Liu J., Pfeffer M.A., et al. Incident hyperkalemia, hypokalemia, and clinical outcomes during spironolactone treatment of heart failure with preserved ejection fraction: analysis of the TOPCAT trial. J Card Fail 2018;24:313—320.
  22. Girerd N., Seronde M.F., Coiro S., et al. Integrative assessment of congestion in heart failure throughout the patient journey. J Am Coll Cardiol HF 2018;6:273—285.
  23. Sowers J.R., Epstein M. Diabetes mellitus and associated hypertension, vascular disease, and nephropathy. An update. Hypertension 1995;26:869—879.
  24. Alper A.B., Campbell R.C., Anker S.D., et al. A propensity-matched study of low serum potassium and mortality in older adults with chronic heart failure. Int J Cardiol 2009;137:1—8.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.